Published in J Neurosci on October 15, 2001
A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proc Natl Acad Sci U S A (2005) 2.02
Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx (2005) 1.10
NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J Psychopharmacol (2009) 0.97
Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day. PLoS One (2011) 0.95
Glutamatergic drive of the dorsal raphe nucleus. J Chem Neuroanat (2011) 0.93
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci (2004) 0.90
Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem (2004) 0.90
Transgenic mouse models for ADHD. Cell Tissue Res (2013) 0.88
Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol (2002) 0.86
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) (2004) 0.85
Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol (2004) 0.84
Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters. Psychopharmacology (Berl) (2005) 0.83
Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels. Front Integr Neurosci (2013) 0.82
A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1). Genes Brain Behav (2015) 0.81
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists. J Neural Transm (Vienna) (2012) 0.80
Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions. Front Pharmacol (2013) 0.79
Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study. Support Care Cancer (2012) 0.76
Substance P, opioid, and catecholamine systems in the mouse central nervous system (CNS). Proc Natl Acad Sci U S A (2002) 0.76
Modeling anorexia nervosa: transcriptional insights from human iPSC-derived neurons. Transl Psychiatry (2017) 0.75
The role of substance P in depression: therapeutic implications. Dialogues Clin Neurosci (2002) 0.75
The future of antidepressant pharmacotherapy. World Psychiatry (2003) 0.75
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet (1985) 4.83
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature (2005) 4.15
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol (2002) 3.75
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med (1992) 3.11
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A (1990) 2.74
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology (1997) 2.61
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis (1999) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell (1994) 2.46
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med (2001) 2.35
Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res (2000) 2.13
Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell (1997) 2.12
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int (2006) 2.07
The challenges of conducting clinical research: one research team's experiences. Clin Nurse Spec (2001) 2.05
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol (2000) 2.03
Neurotransmitter transporters in the central nervous system. Pharmacol Rev (1999) 1.98
A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature (1987) 1.91
Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A (2001) 1.88
Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci (2003) 1.87
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism (1987) 1.76
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
Sensory physiology, anatomy and immunohistochemistry of Rohon-Beard neurones in embryos of Xenopus laevis. J Physiol (1984) 1.68
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus. Science (1990) 1.65
Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int (2006) 1.63
Expression and localization of alpha-adaptin isoforms. J Cell Sci (1995) 1.62
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology (1997) 1.58
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer (2009) 1.54
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int (2006) 1.53
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Ann Oncol (2003) 1.52
Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) (1986) 1.52
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut (2009) 1.49
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology (1999) 1.48
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study. Ann Oncol (1998) 1.47
Cholesterol crystal embolization demonstrated on GI biopsy. Am J Gastroenterol (2001) 1.46
A Schwann cell mitogen accompanying regeneration of motor neurons. Nature (1997) 1.44
Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron (1997) 1.44
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J (1996) 1.41
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J (1996) 1.40
Operation of Randle's cycle in patients with NIDDM. Diabetes (1990) 1.40
Vitamin D status in different subgroups of British Asians. Br Med J (1976) 1.40
Assignment of the human tyrosine hydroxylase gene to chromosome 11. FEBS Lett (1984) 1.39
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. Hepatology (1999) 1.39
CGRP receptor blockade by MK-8825 alleviates allodynia in infraorbital nerve-ligated rats. Eur J Pain (2014) 1.39
Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett (1997) 1.39
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol (1996) 1.39
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet (1989) 1.38
[Determination of mannitol and lactulose in urine by capillary gas chromatography]. Ann Biol Clin (Paris) (1992) 1.38
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol (1985) 1.37
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry (2011) 1.37
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci U S A (2001) 1.37
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci (2001) 1.36
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci (1986) 1.31
Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature (2000) 1.31
Carotid-cavernous fistulas: diagnosis with spiral CT angiography. AJNR Am J Neuroradiol (2000) 1.29
Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci (2000) 1.29
Immunocytochemical localization of glutamic acid decarboxylase in monkey striate cortex. Nature (1981) 1.26
Linkage of tyrosine hydroxylase to four other markers on the short arm of chromosome 11. Nucleic Acids Res (1986) 1.23
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int (1995) 1.22
Neural elements containing glutamic acid decarboxylase (GAD) in the dorsal lateral geniculate nucleus of the rat; immunohistochemical studies by light and electron microscopy. Neuroscience (1983) 1.21
Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int (1998) 1.21
Netrin and netrin receptor expression in the embryonic mammalian nervous system suggests roles in retinal, striatal, nigral, and cerebellar development. Mol Cell Neurosci (1997) 1.20
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol Psychiatry (2007) 1.19
Time dependence of the interaction between lipid and glucose in humans. Am J Physiol (1989) 1.19
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci (1983) 1.18
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology (2005) 1.18
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol (1995) 1.18
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience (1999) 1.18